Skip to main content
Log in

Utility of Bronchoalveolar Lavage and Transbronchial Biopsy in Patients with Interstitial Lung Disease

  • INTERSTITIAL LUNG DISEASE
  • Published:
Lung Aims and scope Submit manuscript

Abstract

Purpose

Bronchoalveolar lavage and transbronchial biopsy can be a useful tool in the evaluation of interstitial lung disease (ILD), but patient selection for this procedure remains poorly defined. Determining clinical characteristics that help with patient selection for bronchoscopy may improve confidence of ILD classification while limiting potential adverse outcomes associated with surgical lung biopsy. The purpose of this study is to identify factors that were associated with change in multidisciplinary ILD diagnosis (MDD) before and after incorporation of BAL and TBBx data.

Methods

We conducted a retrospective cohort study of ILD patients at a single center who underwent bronchoscopy in the diagnostic workup of ILD. We performed sequential MDD both pre- and post-bronchoscopy to calculate the frequency of change in diagnosis after incorporating information from BAL and TBBx and identify features associated with change in diagnosis.

Results

245 patients were included in the study. Bronchoscopy led to a change in diagnosis in 58 patients (23.7%). The addition of TBBx to BAL increased diagnostic yield from 21.8 to 34.1% (p = 0.027). Identification of antigen, HRCT scan inconsistent with UIP, and absence of a pre-bronchoscopy diagnosis of CTD-ILD or IPAF were associated with a change in diagnosis after bronchoscopy.

Conclusion

Our study suggests clinical features that may assist with patient selection for bronchoscopy. We suggest bronchoscopy in patients with identified antigen or an HRCT that is consistent with a non-IPF diagnosis. Appropriate patient selection for bronchoscopy may improve ILD diagnostic confidence and avoid potential complications from more invasive and higher risk procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Data Availability

De-identified data can be made available upon request.

References

  1. Jo HE, Glaspole IN, Levin KC, McCormack SR, Mahar AM, Cooper WA, Cameron R, Ellis SJ, Cottee AM, Webster SE, Troy LK, Torzillo PJ, Corte P, Symons KM, Taylor N, Corte TJ (2016) Clinical impact of the interstitial lung disease multidisciplinary service. Respirology 21(8):1438–1444. https://doi.org/10.1111/resp.12850

    Article  PubMed  Google Scholar 

  2. Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, Behr J, Cottin V, Danoff SK, Morell F, Flaherty KR, Wells A, Martinez FJ, Azuma A, Bice TJ, Bouros D, Brown KK, Collard HR, Duggal A, Galvin L, Inoue Y, Jenkins RG, Johkoh T, Kazerooni EA, Kitaichi M, Knight SL, Mansour G, Nicholson AG, Pipavath SNJ, Buendia-Roldan I, Selman M, Travis WD, Walsh S, Wilson KC, American Thoracic Society ERSJRS, Latin American Thoracic S (2018) Diagnosis of idiopathic pulmonary fibrosis, an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 198(5):e44–e68. https://doi.org/10.1164/rccm.201807-1255ST

    Article  PubMed  Google Scholar 

  3. Meyer KC, Raghu G, Baughman RP, Brown KK, Costabel U, du Bois RM, Drent M, Haslam PL, Kim DS, Nagai S, Rottoli P, Saltini C, Selman M, Strange C, Wood B, American Thoracic Society Committee on BALiILD (2012) An official American thoracic society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 185(9):1004–1014. https://doi.org/10.1164/rccm.201202-0320ST

    Article  Google Scholar 

  4. Sheth JS, Belperio JA, Fishbein MC, Kazerooni EA, Lagstein A, Murray S, Myers JL, Simon RH, Sisson TH, Sundaram B, White ES, Xia M, Zisman D, Flaherty KR (2017) Utility of transbronchial vs surgical lung biopsy in the diagnosis of suspected fibrotic interstitial lung disease. Chest 151(2):389–399. https://doi.org/10.1016/j.chest.2016.09.028

    Article  PubMed  Google Scholar 

  5. Facciolongo N, Patelli M, Gasparini S, Lazzari Agli L, Salio M, Simonassi C, Del Prato B, Zanoni P (2009) Incidence of complications in bronchoscopy, Multicentre prospective study of 20,986 bronchoscopies. Monaldi Arch Chest Dis 71(1):8–14. https://doi.org/10.4081/monaldi.2009.370

    Article  CAS  PubMed  Google Scholar 

  6. Iftikhar IH, Alghothani L, Sardi A, Berkowitz D, Musani AI (2017) Transbronchial lung cryobiopsy and video-assisted thoracoscopic lung biopsy in the diagnosis of diffuse parenchymal lung disease, a meta-analysis of diagnostic test accuracy. Ann Am Thorac Soc 14(7):1197–1211. https://doi.org/10.1513/AnnalsATS.201701-086SR

    Article  PubMed  Google Scholar 

  7. Jin FG, Mu DG, Chu DL, Fu EQ, Xie YH, Liu TG (2008) Severe complications of bronchoscopy. Respiration 76(4):429–433. https://doi.org/10.1159/000151656

    Article  PubMed  Google Scholar 

  8. Ensminger SA, Prakash UB (2006) Is bronchoscopic lung biopsy helpful in the management of patients with diffuse lung disease? Eur Respir J 28(6):1081–1084. https://doi.org/10.1183/09031936.06.00013106

    Article  CAS  PubMed  Google Scholar 

  9. Lynch DA, Sverzellati N, Travis WD, Brown KK, Colby TV, Galvin JR, Goldin JG, Hansell DM, Inoue Y, Johkoh T, Nicholson AG, Knight SL, Raoof S, Richeldi L, Ryerson CJ, Ryu JH, Wells AU (2018) Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper. Lancet Respir Med 6(2):138–153. https://doi.org/10.1016/S2213-2600(17)30433-2

    Article  PubMed  Google Scholar 

  10. Tzilas V, Tzouvelekis A, Bouros E, Karampitsakos T, Ntasiou M, Katsaras M, Costabel U, Wells A, Bouros D (2019) Diagnostic value of BAL lymphocytosis in patients with indeterminate for UIP imaging pattern. Eur Respir J. https://doi.org/10.1183/13993003.01144-2019

    Article  PubMed  Google Scholar 

  11. Troy LK, Grainge C, Corte TJ, Williamson JP, Vallely MP, Cooper WA, Mahar A, Myers JL, Lai S, Mulyadi E, Torzillo PJ, Phillips MJ, Jo HE, Webster SE, Lin QT, Rhodes JE, Salamonsen M, Wrobel JP, Harris B, Don G, Wu PJC, Ng BJ, Oldmeadow C, Raghu G, Lau EMT, Cryobiopsy versus Open Lung biopsy in the Diagnosis of Interstitial lung disease alliance I (2020) Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. Lancet Respir Med 8(2):171–181. https://doi.org/10.1016/S2213-2600(19)30342-X

    Article  CAS  PubMed  Google Scholar 

  12. Silva CI, Muller NL, Lynch DA, Curran-Everett D, Brown KK, Lee KS, Chung MP, Churg A (2008) Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 246(1):288–297. https://doi.org/10.1148/radiol.2453061881

    Article  PubMed  Google Scholar 

  13. Salisbury ML, Gu T, Murray S, Gross BH, Chughtai A, Sayyouh M, Kazerooni EA, Myers JL, Lagstein A, Konopka KE, Belloli EA, Sheth JS, White ES, Holtze C, Martinez FJ, Flaherty KR (2019) Hypersensitivity pneumonitis: radiologic phenotypes are associated with distinct survival time and pulmonary function trajectory. Chest 155(4):699–711. https://doi.org/10.1016/j.chest.2018.08.1076

    Article  PubMed  Google Scholar 

  14. Morisset J, Johannson KA, Jones KD, Wolters PJ, Collard HR, Walsh SLF, Ley B, Collaborators HPD (2018) Identification of diagnostic criteria for chronic hypersensitivity pneumonitis: an international modified delphi survey. Am J Respir Crit Care Med 197(8):1036–1044. https://doi.org/10.1164/rccm.201710-1986OC

    Article  PubMed  PubMed Central  Google Scholar 

  15. Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, Mosca M, Noth I, Richeldi L, Strek ME, Swigris JJ, Wells AU, West SG, Collard HR, Cottin V, CTD-ILD EATFoUFo (2015) An official European respiratory society/American thoracic society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 46(4):976–987. https://doi.org/10.1183/13993003.00150-2015

    Article  CAS  PubMed  Google Scholar 

  16. Tomassetti S, Cavazza A, Colby TV, Ryu JH, Nanni O, Scarpi E, Tantalocco P, Buccioli M, Dubini A, Piciucchi S, Ravaglia C, Gurioli C, Casoni GL, Gurioli C, Romagnoli M, Poletti V (2012) Transbronchial biopsy is useful in predicting UIP pattern. Respir Res 13:96. https://doi.org/10.1186/1465-9921-13-96

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ohshimo S, Bonella F, Cui A, Beume M, Kohno N, Guzman J, Costabel U (2009) Significance of bronchoalveolar lavage for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179(11):1043–1047. https://doi.org/10.1164/rccm.200808-1313OC

    Article  PubMed  Google Scholar 

  18. Coleman A, Colby TV (1988) Histologic diagnosis of extrinsic allergic alveolitis. Am J Surg Pathol 12(7):514–518. https://doi.org/10.1097/00000478-198807000-00002

    Article  CAS  PubMed  Google Scholar 

  19. Sahin H, Brown KK, Curran-Everett D, Hale V, Cool CD, Vourlekis JS, Lynch DA (2007) Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology 244(2):591–598. https://doi.org/10.1148/radiol.2442060640

    Article  PubMed  Google Scholar 

  20. Reyes CN, Wenzel FJ, Lawton BR, Emanuel DA (1982) The pulmonary pathology of farmer's lung disease. Chest 81(2):142–146. https://doi.org/10.1378/chest.81.2.142

    Article  CAS  PubMed  Google Scholar 

  21. Adams TN, Newton CA, Batra K, Abu-Hijleh M, Barbera T, Torrealba J, Glazer CS (2018) Utility of bronchoalveolar lavage and transbronchial biopsy in patients with hypersensitivity pneumonitis. Lung 196(5):617–622. https://doi.org/10.1007/s00408-018-0139-1

    Article  PubMed  PubMed Central  Google Scholar 

  22. Lacasse Y, Selman M, Costabel U, Dalphin JC, Ando M, Morell F, Erkinjuntti-Pekkanen R, Muller N, Colby TV, Schuyler M, Cormier Y, Group HPS (2003) Clinical diagnosis of hypersensitivity pneumonitis. Am J Respir Crit Care Med 168(8):952–958. https://doi.org/10.1164/rccm.200301-137OC

    Article  Google Scholar 

  23. Idiopathic Pulmonary Fibrosis Clinical Research N, Raghu G, Anstrom KJ, King TE, Jr., Lasky JA, Martinez FJ (2012) Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 366(21):1968–1977. https://doi.org/10.1056/NEJMoa1113354

    Article  Google Scholar 

  24. Morisset J, Johannson KA, Vittinghoff E, Aravena C, Elicker BM, Jones KD, Fell CD, Manganas H, Dube BP, Wolters PJ, Collard HR, Ryerson CJ, Ley B (2017) Use of mycophenolate mofetil or azathioprine for the management of chronic hypersensitivity pneumonitis. Chest 151(3):619–625. https://doi.org/10.1016/j.chest.2016.10.029

    Article  PubMed  Google Scholar 

  25. Ravaglia C, Bonifazi M, Wells AU, Tomassetti S, Gurioli C, Piciucchi S, Dubini A, Tantalocco P, Sanna S, Negri E, Tramacere I, Ventura VA, Cavazza A, Rossi A, Chilosi M, La Vecchia C, Gasparini S, Poletti V (2016) Safety and diagnostic yield of transbronchial lung cryobiopsy in diffuse parenchymal lung diseases: a comparative study versus video-assisted thoracoscopic lung biopsy and a systematic review of the literature. Respiration 91(3):215–227. https://doi.org/10.1159/000444089

    Article  PubMed  Google Scholar 

  26. Sethi J, Ali MS, Mohananey D, Nanchal R, Maldonado F, Musani A (2019) Are transbronchial cryobiopsies ready for prime time?: A systematic review and meta-analysis. J Bronchol Interv Pulmonol 26(1):22–32. https://doi.org/10.1097/LBR.0000000000000519

    Article  Google Scholar 

  27. Tukey MH, Wiener RS (2012) Population-based estimates of transbronchial lung biopsy utilization and complications. Respir Med 106(11):1559–1565. https://doi.org/10.1016/j.rmed.2012.08.008

    Article  PubMed  PubMed Central  Google Scholar 

  28. Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM (2002) Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165(12):1581–1586. https://doi.org/10.1164/rccm.2106012

    Article  PubMed  Google Scholar 

  29. Park JH, Kim DS, Park IN, Jang SJ, Kitaichi M, Nicholson AG, Colby TV (2007) Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 175(7):705–711. https://doi.org/10.1164/rccm.200607-912OC

    Article  PubMed  Google Scholar 

  30. Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A, Bozovic G, Denton CP, Black CM, du Bois RM, Wells AU (2008) Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 177(11):1248–1254. https://doi.org/10.1164/rccm.200706-877OC

    Article  PubMed  Google Scholar 

  31. Assayag D, Elicker BM, Urbania TH, Colby TV, Kang BH, Ryu JH, King TE, Collard HR, Kim DS, Lee JS (2014) Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. Radiology 270(2):583–588. https://doi.org/10.1148/radiol.13130187

    Article  PubMed  PubMed Central  Google Scholar 

  32. Solomon JJ, Chung JH, Cosgrove GP, Demoruelle MK, Fernandez-Perez ER, Fischer A, Frankel SK, Hobbs SB, Huie TJ, Ketzer J, Mannina A, Olson AL, Russell G, Tsuchiya Y, Yunt ZX, Zelarney PT, Brown KK, Swigris JJ (2016) Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J 47(2):588–596. https://doi.org/10.1183/13993003.00357-2015

    Article  PubMed  Google Scholar 

  33. Volkmann ER, Tashkin DP, Sim M, Li N, Goldmuntz E, Keyes-Elstein L, Pinckney A, Furst DE, Clements PJ, Khanna D, Steen V, Schraufnagel DE, Arami S, Hsu V, Roth MD, Elashoff RM, Sullivan KM, Sls I, groups SIs, (2019) Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts. Ann Rheum Dis 78(1):122–130. https://doi.org/10.1136/annrheumdis-2018-213708

    Article  PubMed  Google Scholar 

Download references

Funding

Author CN has Grant funding from NHLBI (NHLBI K23HL148498).

Author information

Authors and Affiliations

Authors

Contributions

TNA, KB, LS, VA, TB, YB, JT, JAN, and CSG contributed substantially to the study design, data analysis and interpretation, and the writing of the manuscript.

Corresponding author

Correspondence to Traci N. Adams.

Ethics declarations

Conflict of interest

The authors TNA, KB, LS, VA, EJ, SM, YB, JT, JAN, and CSG have no conflicts of interest to report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adams, T.N., Batra, K., Silhan, L. et al. Utility of Bronchoalveolar Lavage and Transbronchial Biopsy in Patients with Interstitial Lung Disease. Lung 198, 803–810 (2020). https://doi.org/10.1007/s00408-020-00389-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-020-00389-4

Keywords

Navigation